schliessen

Filtern

 

Bibliotheken

Neutrophil/lymphocyte ratio is a more sensitive systemic inflammatory response biomarker than platelet/lymphocyte ratio in the prognosis evaluation of unresectable pancreatic cancer.

Multiple cancers arise from sites of infection, chronic irritation, and inflammation. It has been widely accepted that pancreatic cancer is an inflammation-driven cancer. In this study, we investigated the application value of systemic inflammatory markers, neutrophil to lymphocyte ratio (NLR) and p... Full description

Journal Title: Oncotarget October 24, 2017, Vol.8(51), pp.88835-88844
Main Author: Gao, Yuan
Other Authors: Wang, Wen-Jie , Zhi, Qiaoming , Shen, Meng , Jiang, Min , Bian, Xiaojie , Gong, Fei-Ran , Zhou, Chong , Lian, Lian , Wu, Meng-Yao , Feng, Jun , Tao, Min , Li, Wei
Format: Electronic Article Electronic Article
Language: English
Subjects:
ID: E-ISSN: 1949-2553 ; DOI: 10.18632/oncotarget.21340
Link: http://search.proquest.com/docview/1969924358/?pq-origsite=primo
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: proquest1969924358
title: Neutrophil/lymphocyte ratio is a more sensitive systemic inflammatory response biomarker than platelet/lymphocyte ratio in the prognosis evaluation of unresectable pancreatic cancer.
format: Article
creator:
  • Gao, Yuan
  • Wang, Wen-Jie
  • Zhi, Qiaoming
  • Shen, Meng
  • Jiang, Min
  • Bian, Xiaojie
  • Gong, Fei-Ran
  • Zhou, Chong
  • Lian, Lian
  • Wu, Meng-Yao
  • Feng, Jun
  • Tao, Min
  • Li, Wei
subjects:
  • Neutrophil to Lymphocyte Ratio (Nlr)
  • Pancreatic Cancer
  • Platelet to Lymphocyte Ratio (Plr)
  • Systemic Inflammatory Response (Sir)
ispartof: Oncotarget, October 24, 2017, Vol.8(51), pp.88835-88844
description: Multiple cancers arise from sites of infection, chronic irritation, and inflammation. It has been widely accepted that pancreatic cancer is an inflammation-driven cancer. In this study, we investigated the application value of systemic inflammatory markers, neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR), in the prediction of chemotherapy response and prognosis in patients with late pancreatic cancer. 122 patients with inoperable pancreatic cancers were included and separated into two groups according to median values of NLR or PLR (NLR low:
language: eng
source:
identifier: E-ISSN: 1949-2553 ; DOI: 10.18632/oncotarget.21340
fulltext: fulltext
issn:
  • 19492553
  • 1949-2553
url: Link


@attributes
ID1133797880
RANK0.07
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
LOCALfalse
PrimoNMBib
record
control
sourcerecordid1969924358
sourceidproquest
recordidTN_proquest1969924358
sourcesystemPC
pqid1969924358
display
typearticle
titleNeutrophil/lymphocyte ratio is a more sensitive systemic inflammatory response biomarker than platelet/lymphocyte ratio in the prognosis evaluation of unresectable pancreatic cancer.
creatorGao, Yuan ; Wang, Wen-Jie ; Zhi, Qiaoming ; Shen, Meng ; Jiang, Min ; Bian, Xiaojie ; Gong, Fei-Ran ; Zhou, Chong ; Lian, Lian ; Wu, Meng-Yao ; Feng, Jun ; Tao, Min ; Li, Wei
contributorGao, Yuan (correspondence author) ; Gao, Yuan (record owner)
ispartofOncotarget, October 24, 2017, Vol.8(51), pp.88835-88844
identifierE-ISSN: 1949-2553 ; DOI: 10.18632/oncotarget.21340
subjectNeutrophil to Lymphocyte Ratio (Nlr) ; Pancreatic Cancer ; Platelet to Lymphocyte Ratio (Plr) ; Systemic Inflammatory Response (Sir)
languageeng
source
descriptionMultiple cancers arise from sites of infection, chronic irritation, and inflammation. It has been widely accepted that pancreatic cancer is an inflammation-driven cancer. In this study, we investigated the application value of systemic inflammatory markers, neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR), in the prediction of chemotherapy response and prognosis in patients with late pancreatic cancer. 122 patients with inoperable pancreatic cancers were included and separated into two groups according to median values of NLR or PLR (NLR low:<3.81 or NLR high:≥3.81, and PLR low:<142.14 or PLR high≥142.14, respectively). Baseline NLR and PLR levels were significantly higher in pancreatic cancer patients compared with the healthy subjects. Neither of the baseline NLR or PLR levels could predict outcomes. Patients with low baseline level of NLR, but not PLR, had better responses to chemotherapy. Changes in NLR, but not PLR levels, were associated with the therapeutic efficacy. Patients who stayed in or dropped into the low NLR level subgroup after first-line chemotherapy had better responses, comparing to those stayed in or jumped into the high NLR level group. No similar results could be observed when the PLR level was investigated. Therefore, NLR is a more sensitive biomarker than PLR in the prediction of chemotherapy response of patients.
version4
lds50peer_reviewed
links
openurl$$Topenurl_article
openurlfulltext$$Topenurlfull_article
backlink$$Uhttp://search.proquest.com/docview/1969924358/?pq-origsite=primo$$EView_record_in_ProQuest_(subscribers_only)
search
creatorcontrib
0Gao, Yuan
1Wang, Wen-Jie
2Zhi, Qiaoming
3Shen, Meng
4Jiang, Min
5Bian, Xiaojie
6Gong, Fei-Ran
7Zhou, Chong
8Lian, Lian
9Wu, Meng-Yao
10Feng, Jun
11Tao, Min
12Li, Wei
titleNeutrophil/lymphocyte ratio is a more sensitive systemic inflammatory response biomarker than platelet/lymphocyte ratio in the prognosis evaluation of unresectable pancreatic cancer.
subject
0Neutrophil to Lymphocyte Ratio (Nlr)
1Pancreatic Cancer
2Platelet to Lymphocyte Ratio (Plr)
3Systemic Inflammatory Response (Sir)
4neutrophil to lymphocyte ratio (NLR)
5pancreatic cancer
6platelet to lymphocyte ratio (PLR)
7systemic inflammatory response (SIR)
general
0English
110.18632/oncotarget.21340
2MEDLINE (ProQuest)
3ProQuest Biological Science Collection
4ProQuest Natural Science Collection
5ProQuest SciTech Collection
6Biological Science Database
7Natural Science Collection
8SciTech Premium Collection
9Health Research Premium Collection
10Health Research Premium Collection (Alumni edition)
11Biological Science Index (ProQuest)
sourceidproquest
recordidproquest1969924358
issn
019492553
11949-2553
rsrctypearticle
creationdate2017
addtitleOncotarget
searchscope
01007527
11007944
21009130
310000004
410000038
510000050
610000120
710000159
810000238
910000253
1010000260
1110000270
1210000271
1310000302
1410000350
15proquest
scope
01007527
11007944
21009130
310000004
410000038
510000050
610000120
710000159
810000238
910000253
1010000260
1110000270
1210000271
1310000302
1410000350
15proquest
lsr43
01007527false
11007944false
21009130false
310000004false
410000038false
510000050false
610000120false
710000159false
810000238false
910000253false
1010000260false
1110000270false
1210000271false
1310000302false
1410000350false
contributorGao, Yuan
startdate20171024
enddate20171024
citationpf 88835 pt 88844 vol 8 issue 51
lsr30VSR-Enriched:[description, pqid]
sort
titleNeutrophil/lymphocyte ratio is a more sensitive systemic inflammatory response biomarker than platelet/lymphocyte ratio in the prognosis evaluation of unresectable pancreatic cancer.
authorGao, Yuan ; Wang, Wen-Jie ; Zhi, Qiaoming ; Shen, Meng ; Jiang, Min ; Bian, Xiaojie ; Gong, Fei-Ran ; Zhou, Chong ; Lian, Lian ; Wu, Meng-Yao ; Feng, Jun ; Tao, Min ; Li, Wei
creationdate20171024
lso0120171024
facets
frbrgroupid6113407381267528047
frbrtype5
newrecords20181218
languageeng
creationdate2017
topic
0Neutrophil to Lymphocyte Ratio (Nlr)
1Pancreatic Cancer
2Platelet to Lymphocyte Ratio (Plr)
3Systemic Inflammatory Response (Sir)
collection
0MEDLINE (ProQuest)
1ProQuest Biological Science Collection
2ProQuest Natural Science Collection
3ProQuest SciTech Collection
4Biological Science Database
5Natural Science Collection
6SciTech Premium Collection
7Health Research Premium Collection
8Health Research Premium Collection (Alumni edition)
9Biological Science Index (ProQuest)
prefilterarticles
rsrctypearticles
creatorcontrib
0Gao, Yuan
1Wang, Wen-Jie
2Zhi, Qiaoming
3Shen, Meng
4Jiang, Min
5Bian, Xiaojie
6Gong, Fei-Ran
7Zhou, Chong
8Lian, Lian
9Wu, Meng-Yao
10Feng, Jun
11Tao, Min
12Li, Wei
jtitleOncotarget
toplevelpeer_reviewed
delivery
delcategoryRemote Search Resource
fulltextfulltext
addata
aulast
0Gao
1Wang
2Zhi
3Shen
4Jiang
5Bian
6Gong
7Zhou
8Lian
9Wu
10Feng
11Tao
12Li
aufirst
0Yuan
1Wen-Jie
2Qiaoming
3Meng
4Min
5Xiaojie
6Fei-Ran
7Chong
8Lian
9Meng-Yao
10Jun
11Wei
au
0Gao, Yuan
1Wang, Wen-Jie
2Zhi, Qiaoming
3Shen, Meng
4Jiang, Min
5Bian, Xiaojie
6Gong, Fei-Ran
7Zhou, Chong
8Lian, Lian
9Wu, Meng-Yao
10Feng, Jun
11Tao, Min
12Li, Wei
addauGao, Yuan
atitleNeutrophil/lymphocyte ratio is a more sensitive systemic inflammatory response biomarker than platelet/lymphocyte ratio in the prognosis evaluation of unresectable pancreatic cancer.
jtitleOncotarget
risdate20171024
volume8
issue51
spage88835
epage88844
pages88835-88844
eissn1949-2553
formatjournal
genrearticle
ristypeJOUR
doi10.18632/oncotarget.21340
urlhttp://search.proquest.com/docview/1969924358/
date2017-10-24